Property:Metabolization

From Psychiatrienet
Revision as of 10:40, 21 April 2010 by Musys (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Metabolization is defined within this context as a property of a drug, and will be displayed on combination pages. Text

Showing 12 pages using this property.
A
*Aripiprazole is metabolized by CYP2D6 and CYP3A4 to an active metabolite.   +
*Aripiprazole is metabolized by CYP2D6 and CYP3A4 to an active metabolite.   +
C
* Carbamazepine is principally metabolized by CYP3A4, and is a potent inducer of CYP1A2, CYP2C9, CYP3A4 and UDP-glucuronosyltransferases.   +
G
* Gabapentin is eliminated unchanged by the kidney for 100%.   +
L
* Lamotrigine is principally metabolised by UDP-glucuronosyltransferases.   +
* Lithium is eliminated by the kidney for about 95%. Changes in the rate of excretion can cause unwanted effects.   +
O
* Olanzapine is principally metabolized by CYP1A2 and CYP2D6.   +
Q
* Quetiapine is principally metabolized by CYP3A4 to active and inactive metabolites.   +
R
* Risperidone is principally metabolized by CYP2D6 to an active metabolite 9-OH-risperidone (paliperidone).   +
T
* Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.   +
V
* Valproic acid is principally metabolized by CYP2C9, CYP2C19, CYP2A6 and UDP-glucuronosyltransferases. Valproic acid is an inhibitor of the enzymes CYP2C9, epoxide-hydroxylase and UDP-glucuronosyltransferases.   +
Z
* Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.   +